investor-targeting — independently scanned and version-tracked by SaferSkills.
SaferSkills independently audited investor-targeting (Agent Skill) and scored it 100/100 (green). The audit ran 55 deterministic rules across Security, Supply Chain, Maintenance, Transparency, and Community; it found 0 high-severity and 0 lower-severity findings. The full rule-by-rule trace and per-finding evidence are below. Free, methodology-open.
Findings & checks · 0 flagged
Every scanned point with the score it earned and what moved between them.
First recorded scan — no prior version to compare against.
The primary manifest — the file an agent reads to learn what this artifact does.
A raise is a sales process, and a sales process with the wrong leads fails no matter how good the pitch. Most founders spray a generic list and wonder why conversion is low. This skill builds a tight, researched, warm-path-first list.
Use it once [[fundraising-stage-selector]] fixes the stage and check size, and before [[vc-pitch-email]] writes outreach. Feed the output into [[investor-pipeline-crm]] to run the process.
Score each prospective investor on:
fund "being nice" at pre-seed wastes a meeting.
their recent deals and partner writing.
(conflict kills the deal and risks your data).
brings. Name it, or they are just capital.
you internally. Target the right partner by name.
and domain help. Smaller checks; assemble a syndicate.
the strings before you pursue.
Build the round as a mix — a lead plus angels who add signal and help.
Cold works, warm wins. For every target, find the strongest introduction path:
intro with a forwardable blurb you write for them.
competitive window.
Never burn a Tier 1 cold on day one with an unrehearsed pitch.
A ranked target list (30-60 names) with stage/thesis/portfolio fit scored, the specific value each adds, the named partner, the warm-intro path and referrer for each, and a tiered sequencing plan. Load it into [[investor-pipeline-crm]].
~30 seconds. Free. No account. Every finding cites a rule and a line of evidence.